Protara Therapeutics
TARA
24 hedge funds and large institutions have $87.8M invested in Protara Therapeutics in 2014 Q4 according to their latest regulatory filings, with 24 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
A
Abingworth
London,
United Kingdom
|
+$20.3M |
| 2 |
DM
Deerfield Management
New York
|
+$12.8M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$12.6M |
| 4 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
+$9.91M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.57M |
Top Sellers
TARA Hedge Fund Activity: Q4 2014 in Review
24 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q4 2014, worth a combined $87.8M.
Buyers outnumbered sellers: 24 funds opened new TARA positions and 0 closed out — a net gain of 24 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Abingworth, opening a new position worth an estimated $20.3M.
- 24 institutional investors held Protara Therapeutics (TARA) as of Q4 2014, up from 0 in Q3 2014.
- Funds reported $87.8M of Protara Therapeutics stock for Q4 2014.
- 24 funds opened new Protara Therapeutics positions in Q4 2014 and 0 closed out, a net change of +24 holders.
- The largest Protara Therapeutics buyer in Q4 2014 was Abingworth, an estimated $20.3M added.
Based on aggregated 13F filings for Q4 2014.